Novum Peptides

Research use only

Before you enter

Please confirm the following before browsing Novum Peptides.

Adults onlyYou must be 18 years or older to enter.

Laboratory research onlyOur products are not for human or veterinary use.

We’ll remember your confirmation on this browser where storage is available.

Novum Peptides · For laboratory research only

Asparagine and glutamine side-chain chemistry

Distinguish Asn and Gln side-chain amides from terminal amidation, and understand why deamidation needs a specified site, product and chemical setting.

Asparagine and glutamine carry amide groups in their side chains. Their similar names and structures can make several different changes look interchangeable: replacing a residue, amidating a chain end and deamidating a side chain. Locating the group first prevents that confusion.

One extra methylene changes the side chain

Asparagine, Asn or N, has a –CH2–C(=O)–NH2 side chain. Glutamine, Gln or Q, has –CH2–CH2–C(=O)–NH2. The curated ChEBI structures show the additional methylene group in glutamine. Both groups are amides, rather than free side-chain amines.ChEBI — L-asparagine, CHEBI:17196 (opens in a new tab)ChEBI — L-glutamine, CHEBI:18050 (opens in a new tab)

Locate the amide being discussed
FeatureWhere it is found
Asn side-chain amideOne methylene beyond the alpha carbon
Gln side-chain amideTwo methylenes beyond the alpha carbon
Backbone peptide bondBetween successive conventional residues
C-terminal amideAt a chemically modified carboxyl end

These positions are not interchangeable in a structure record. A peptide containing Q is not thereby C-terminally amidated. Likewise, an –NH2 suffix at the chain end does not declare the presence of an extra glutamine residue.

Deamidation concerns a chemical transformation

A deamidation description should name the starting residue and the resulting chemical species. In peptide research, an Asn-derived product may involve more than simply changing the letter N to D in an otherwise unchanged sketch.

Capasso and colleagues studied the model peptide Boc–Asn–Gly–Gly–NH2. They observed a pathway through a succinimide intermediate giving aspartyl and isoaspartyl products; the reaction rate depended on the medium. This is a defined model-peptide result, not a rate assigned to every asparagine-containing sequence.Capasso and colleagues — Deamidation via cyclic imide (opens in a new tab)

The distinction between aspartyl and isoaspartyl products matters because their connection through the peptide differs. If the analytical assignment leaves those products unresolved, preserve that uncertainty rather than reporting one exact structure.

A universal Asn-versus-Gln rate rule is unsafe

Joshi and Kirsch compared deamidation in glucagon fragment 22–29 under acidic, elevated-temperature conditions. In that system, the glutamine residue deamidated more readily than the asparagine residue. The observation demonstrates why a broad ranking should not replace the actual sequence and conditions.Joshi and Kirsch — Relative deamidation rates in glucagon fragment 22–29 (opens in a new tab)

It would be equally misleading to turn that counterexample into a new universal rule that glutamine always reacts faster. The useful conclusion is narrower: the relative behaviour in one chemical setting needs to be established, not inferred from a short mnemonic.

When comparing two studies, retain differences in molecular form and experimental environment before comparing their rates. Otherwise, a table can place unlike measurements side by side while making them appear directly comparable.

Keep the original and modified sequence distinct

Imagine a hypothetical chain with Asn at position 4 and Gln at position 9. A report says one deamidated species was detected but does not resolve the site. Writing N4D would add information the report has not supplied. A defensible record says the modification is detected and its position remains unassigned.

If later evidence resolves the site, update the assignment while retaining the link to that evidence. If it resolves a mixture, record the mixture. Neither a clean-looking chromatographic peak nor an abbreviated product name should silently decide the structural answer.

This approach keeps a reference sequence separate from the measured state of a particular sample. It also makes comparisons between a proposed degradation pathway and an observed product easier to audit.

Use the chemistry at the right level

  • Locate the side-chain amide rather than relying on the word amidated.
  • Name the residue position and the proposed product.
  • Check whether the source resolves alternative products or reports a mixture.
  • Retain the conditions behind any rate comparison.

These details explain a molecular transformation. They do not establish an expiry date, prescribe storage conditions or determine the biological activity of the resulting material without separate evidence.

Sources and further detail

  1. ChEBI — L-asparagine, CHEBI:17196 (opens in a new tab)

    Curated molecular structure and nomenclature.

  2. ChEBI — L-glutamine, CHEBI:18050 (opens in a new tab)

    Curated molecular structure, including the additional methylene group relative to asparagine.

  3. Capasso and colleagues — Deamidation via cyclic imide (opens in a new tab)

    Peptide Research 4, 234–238 (1991). Primary model-peptide study; public abstract describes succinimide, aspartyl and isoaspartyl products and dependence on medium.

  4. Joshi and Kirsch — Relative deamidation rates in glucagon fragment 22–29 (opens in a new tab)

    Journal of Pharmaceutical Sciences 91, 2331–2345 (2002), DOI 10.1002/jps.10213. Acidic, elevated-temperature model study; not a shelf-life result.

Sources checked 19 September 2026. Worked examples are illustrative unless a supplied report is explicitly identified. This article has not undergone independent scientific peer review.